Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute of Innovative Biomedical Technologies (IIBT) is a Latvian biotechnology company focused on the development of functional foods and nutraceuticals derived from natural sources. The institute specializes in creating bioactive products that address iron deficiency, metabolic disorders, and the side effects of oncological treatments. Led by Dr. Dmitry Babarykin, IIBT combines traditional natural medicine with modern biotechnological processes to produce clinically validated supplements. Their portfolio includes innovative iron-delivery systems and betulin-based formulations designed to enhance patient health and recovery. IIBT operates its own research and development facilities in Riga and maintains strong ties with academic institutions for clinical testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Innovative Biomedical Technologies.